Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 20 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 11267782

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  2. US 11267845

    Inhibitors of CD73-mediated immunosuppression

    Arcus Biosciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  3. US 11261152

    Inhibitors of the N-terminal domain of the androgen receptor

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  4. US 11261231

    Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  5. US 11261197

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  6. US 11254667

    Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  7. US 11254683

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  8. US 11254664

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  9. US 11254669

    Fused imidazo-piperidine JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  10. US 11247971

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  11. US 11247985

    Phenyl indole allosteric inhibitors of P97 ATPase

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  12. US 11242333

    Inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  13. US 11236044

    Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  14. US 11236080

    Protein kinase inhibitors

    Princeton Drug Discovery, Inc · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  15. US 11230530

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted
  16. US 11230544

    Substituted 1,3,4-thiadiazoles as GLS1 inhibitors

    Medshine Discovery Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted
  17. US 11229679

    Compositions for treating heart disease by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted
  18. US 11230537

    Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted
  19. US 11230542

    Inhibitors of integrated stress response pathway

    PRAXIS BIOTECH LLC · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted
  20. US 11225477

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  21. US 11225469

    Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  22. US 11220509

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Mirati Therapeutics, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted
  23. US 11220479

    Glucosylceramide synthase inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted
  24. US 11220486

    Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted